• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Virendra Pandit

Ahmedabad, Jan 17 The Ahmedabad-based Intas Biopharmaceuticals Ltd on Thursday announced plans to supply and market indigenously-developed biotech products in the Gulf Cooperation Council (GCC) region. The GCC comprises six countries, viz. Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the UAE.

Initially, the company is looking to supply and market three products, i.e., Neukine, Erykine and Intalfa, a company official said here. IBPL has now initiated procedure of submitting the required technical documents for product registration in the GCC region.

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Sunil Hitech raises Rs 81 cr

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line